[1]
“DEVELOPMENT OF TARGETED NANOPARTICLE DRUG DELIVERY FOR SURGICAL CANCER THERAPY: EFFECTS ON PHARMACOKINETICS, TUMOR ACCUMULATION, THERAPEUTIC EFFICACY, AND SYSTEMIC TOXICITY”, Biosci. Insights., vol. 3, no. 02, pp. 854–864, Aug. 2026, Accessed: Nov. 10, 2026. [Online]. Available: https://biosciinsights.com/index.php/BI/article/view/133